Company intelligence / Profile preview

Aerolase

Tarrytown, New York, United Statesaerolase.ru ↗

Ownership: Private
Employees: ~120
Development stage: Commercial

Overview

Aerolase has developed a proprietary portable high-power laser platform with over two decades of R&D. Their devices are FDA-cleared for more than three dozen dermatological and aesthetic indications. The company emphasizes safety across all skin types—including darker tones—minimal discomfort or downtime, and rapid visible results. They have achieved strong commercial growth with global adoption in over 50 countries.

Therapeutic areas: Dermatology
Modalities: Device (Laser-based medical device)
Industry: Therapeutic Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed; focus on direct sales to clinics/practitioners.

Beyond the preview

Go deeper on Aerolase.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aerolase.

Explore the full profile